News

PredictImmune’s Prognostic Biomarker Test for IBD to feature in Platform Presentations at Upcoming Conferences

Cambridge, UK, 17th September 2018:  PredictImmune’s first product, a prognostic biomarker test for IBD will be the subject of two key presentations at upcoming conferences in the coming weeks.  The presentations will be an opportunity to hear about ground-breaking research currently being carried out in the field of IBD at the University of Cambridge.

Swiss Society of Gastroenterology Annual Meeting 2018


27th-28th September, Congress Centre Kursaal, Interlaken, Switzerland

Dr. James Lee will present ‘Practical implications of genetics in IBD’ as part of the IBD Session from 8:00-10:00 am, on Thursday 27th September.  This is an excellent opportunity to catch up on the latest developments in IBD, including the use of the prognostic biomarkers to drive personal medicine.

https://sgg-sgvc-sasl.unibas.ch/program-en.php

The Falk Foundation, Symposium 213: Tailored Therapies for IBD: A Look into the Future

October 5 – 6, Milan Marriott Hotel, Milan, Italy

The Falk Foundation offers a broad spectrum of events promoting the exchange of knowledge, as well as postgraduate courses in gastroenterology and hepatology. The International symposia provide scientists and doctors with a first-class platform for exchanging knowledge in pure and clinical research.

Dr. Nurulamin Noor, will be presenting a poster entitled “PROFILE trial: PRedicting Outcomes For Crohn’s dIsease using a moLecular biomarker” on Friday 4th October.  This poster has been selected as one of the presentations of distinction by the organising committee of the meeting.

http://www.falk-foundation-symposia.org/uploads/tx_tocfpshoperw/S213_Milan_2018_Preliminary_Program.pdf